South Texas Accelerated Research Therapeutics Midwest — Grand Rapids, Michigan

South Texas Accelerated Research Therapeutics Midwest is a clinical research site located in Grand Rapids, Michigan, United States 49546.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

South Texas Accelerated Research Therapeutics Midwest has participated in 1 clinical trials.

Therapeutic areas: Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Neoplasms, Ovarian Neoplasms.

Sponsors: Seagen Inc..

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for South Texas Accelerated Research Therapeutics Midwest?

South Texas Accelerated Research Therapeutics Midwest has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has South Texas Accelerated Research Therapeutics Midwest conducted?

South Texas Accelerated Research Therapeutics Midwest has 1 clinical trials on record. Their work covers Carcinoma, Non-Small Cell Lung, HER2 Negative Breast Neoplasms, Ovarian Neoplasms.

Is South Texas Accelerated Research Therapeutics Midwest accredited by Crixeo Health?

South Texas Accelerated Research Therapeutics Midwest has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about South Texas Accelerated Research Therapeutics Midwest?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.